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age of drugs available for effective the IV form, then switch to the oral once the infection is better contreatment of MRSA infections," according to Page. trolled," adds Man. BAL 8557 is just about to enter phase I testing. The BAL 5788 has also exhibited activity against penicillin-resistant Strepother antifungal effort is a preclinical project focused on inhibition of glutococcus pneumonia, viridans streptococci, and coagulase-negative can synthase. "We have a number of molecules from this field," he says, staphlycocci such as Staphylococcus epidermidis. "Staphylococcus is "and we'll probably decide by the end of the year how to proceed with the most common cause of infection in humans," says Man. "You'll find this group of compounds." Natural Products Library and the infections both in the out-patient community and hospital settings." It Chemistry Automation When Basilea was formed, it also inis also commonly involved in wound (skin and soft tissue) infections.
herited a "natural products strain collection," a microbe library of Streptococcal infections are commonly acquired as lower respiratory 120,000 organisms, each with the potential or proven ability to syntheinfections. "In fact, Streptococcus pneumonia is the lead cause of comsize antibiotics or other therapeutic agents. "We have access to several munity-acquired bacterial pneumo-
